Stryker Hip Lawsuit Deadline Approaching, Notes Hissey Kientz, LLP
Austin, TX (PRWEB) June 17, 2014 -- Stryker Corporation issued a recall of the Stryker Rejuvenate and Stryker ABG II artificial hip replacement systems in July 2012. Plaintiffs living in states with a two year statute of limitation may only have until July 2014 to file a lawsuit against Stryker Corporation, according to Hissey Kientz, LLP.
Stryker Corporation issued the voluntary recall after the hip implants were linked to serious complications including fretting, corrosion, metallosis, hip dislocation and fractures.*
The Stryker Rejuvenate and Stryker ABG II hip replacements include metal neck and stem components that can grind together over time, causing metal debris to flake off of the implant. According to the British Medical Journal, metal debris can release toxic levels of chromium and cobalt ions into the bloodstream, leading to metal poisoning.**
Both the Stryker Rejuvenate and Stryker ABG hip replacement systems were submitted through the Food and Drug Administration’s 510(k) program, which allows manufacturers to bypass clinical trials if their device is substantially similar to a device already approved by the FDA.
Patients who have experienced metal poisoning, fractures, or implant dislocation from a Stryker Rejuvenate or Stryker ABG II hip replacement system may wish to speak with a lawyer to find out if they are eligible to file a lawsuit. For more information about whether you may have a case, contact the attorneys at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by email at info(at)hkllp(dot)com.
** http://www.bmj.com/content/344/bmj.e1349
About Hissey Kientz, LLP
Hissey Kientz, LLP represents individuals affected by Stryker hip replacement failure, as well as victims of mesothelioma and other asbestos-related diseases, birth defects linked to the antidepressant drugs Zoloft, Lexapro, Celexa, Paxil and Effexor, problems with transvaginal mesh, gynecomastia from Risperdal, DePuy ASR and Pinnacle hip replacements, GranuFlo dialysis concentrate, Mirena birth control, and other defective drugs and medical devices.
Allison Sass, Hissey Kientz LLP, +1 (866) 275-4454, [email protected]
Share this article